Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Lower risk of Multi-system inflammatory syndrome in children (MIS-C) with the omicron variant.

ABSTRACT:

SUBMITTER: Lopez L

PROVIDER: S-EPMC9541565 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Lower risk of Multi-system inflammatory syndrome in children (MIS-C) with the omicron variant.

Lopez Laura L Burgner David D Glover Catherine C Carr Jeremy J Clark Julia J Boast Alison A Vasilunas Nan N McMullan Brendan B Francis Joshua R JR Bowen Asha C AC Blyth Christopher C CC Macartney Kristine K Crawford Nigel W NW Carey Emma E Wood Nicholas N Britton Philip N PN

The Lancet regional health. Western Pacific 20221007

PMID: 36237982

Similar Datasets

Short-term Cardiovascular Complications of Multi-system Inflammatory Syndrome in Children (MIS-C) in Adolescents and Children.

Project description: Not available

| S-EPMC8531914 | biostudies-literature

Multisystem inflammatory syndrome in children (MIS-C) serum proteomics

Project description:While fewer cases of severe Coronavirus Disease 2019 (COVID-19) are reported globally in children, a small proportion of SARS-CoV-2 infected children develop a novel pediatric febrile entity called multisystem inflammatory syndrome in children (MIS-C) that develops 2 to 5 weeks after initial SARS-CoV-2 exposure. MIS-C primarily effects male children and children of Hispanic or black descent. MIS-C manifests as a severe and uncontrolled inflammatory response with multiorgan involvement. A hyperinflammatory state is evidenced by clinical makers of inflammation including high levels of C-reactive protein (CRP), ferritin, and D-dimers, and an increased expression of pro-inflammatory cytokines. Children often present with persistent fever, severe gastrointestinal symptoms, cardiovascular manifestations, respiratory symptoms and neurological symptoms6-11,13. Cardiovascular manifestations include hypotension, shock, cardiac dysfunction, myocarditis and pericardial effusion. In the united states, admission to the intensive care unit occurs in approximately 58% of cases. To understand disease pathogenesis of MIS-C and proteins associated with the severe form of disease we performed proteomics analysis of serum or plasma samples. We collected serum from healthy children (SARS-CoV-2 negative, n=20), mild MIS-C (non-ICU, n=5) and severe MIS-C (ICU, n = 20) patients. MIS-C definition and diagnosis was performed according to CDC guidelines. Healthy adult serum (n = 4) was also used for reference ranges quality control and we obtained plasma samples from Kawasaki Disease (KD; n=7) patients that were recruited before the Coronavirus Disease 2019 (COVID-19) pandemic.

2021-09-29 | PXD025462 | Pride

A case report of multi-system inflammatory syndrome in adults (MIS-A) associated with heart failure.

Project description: Not available

| S-EPMC8511808 | biostudies-literature

Editorial: COVID-19 and Multisystem Inflammatory Syndrome in Children (MIS-C).

Project description: Not available

| S-EPMC8176784 | biostudies-literature

Innate immune dysregulation in multisystem inflammatory syndrome in children (MIS-C).

Project description: Not available

| S-EPMC10542373 | biostudies-literature

Diagnosis of multisystem inflammatory syndrome in children (MIS-C) by a whole-blood transcriptional signature

Project description:Multisystem inflammatory syndrome in children (MIS-C) occurs in some children approximately 2-6 weeks following infection with SARS-CoV-2. Clinical symptoms are highly overlapping with Kawasaki disease (KD) and bacterial (DB) and viral (DV) infections, making diagnosis particularly challenging. Host whole blood transcriptomics can reveal specific combinations of host genes whose expression patterns can distinguish between disease groups of interest. We performed whole blood RNA-Sequencing of individuals with MIS-C, KD, bacterial and viral infections to identify a number of host genes that, when combined, could be used to diagnose MIS-C. This data contains processed data only. Raw data will be available via a controlled access archive.

2023-06-27 | E-MTAB-12793 | biostudies-arrayexpress

Heterozygous BTNL8 variants in individuals with multisystem inflammatory syndrome in children (MIS-C).

Project description: Not available

| S-EPMC11586762 | biostudies-literature

Treatments for multi-system inflammatory syndrome in children - discharge, fever, and second-line therapies.

Project description: Not available

| S-EPMC9595092 | biostudies-literature

Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C).

Project description: Not available

| S-EPMC7359537 | biostudies-literature

Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Covid-19 - Single-Center Experience.

Project description: Not available